nodes	percent_of_prediction	percent_of_DWPC	metapath
Medrysone—NR3C1—type 2 diabetes mellitus	0.878	1	CbGaD
Medrysone—Visual disturbance—Repaglinide—type 2 diabetes mellitus	0.00211	0.0444	CcSEcCtD
Medrysone—Glaucoma—Gliclazide—type 2 diabetes mellitus	0.00209	0.044	CcSEcCtD
Medrysone—NR3C1—Endoderm Differentiation—HHEX—type 2 diabetes mellitus	0.0018	0.031	CbGpPWpGaD
Medrysone—Finasteride—SRD5A1—type 2 diabetes mellitus	0.00177	0.137	CrCbGaD
Medrysone—Visual disturbance—Glipizide—type 2 diabetes mellitus	0.00175	0.0367	CcSEcCtD
Medrysone—Viral infection—Gliclazide—type 2 diabetes mellitus	0.00175	0.0367	CcSEcCtD
Medrysone—Visual disturbance—Pioglitazone—type 2 diabetes mellitus	0.00167	0.0352	CcSEcCtD
Medrysone—Viral infection—Valsartan—type 2 diabetes mellitus	0.0016	0.0337	CcSEcCtD
Medrysone—Visual disturbance—Bromocriptine—type 2 diabetes mellitus	0.00147	0.0309	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—G6PC—type 2 diabetes mellitus	0.00147	0.0252	CbGpPWpGaD
Medrysone—Stinging—Losartan—type 2 diabetes mellitus	0.00145	0.0304	CcSEcCtD
Medrysone—Visual disturbance—Glyburide—type 2 diabetes mellitus	0.00135	0.0283	CcSEcCtD
Medrysone—Visual impairment—Repaglinide—type 2 diabetes mellitus	0.00134	0.028	CcSEcCtD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA6—type 2 diabetes mellitus	0.0013	0.0223	CbGpPWpGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—INSR—type 2 diabetes mellitus	0.00129	0.0222	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—type 2 diabetes mellitus	0.00125	0.0214	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—type 2 diabetes mellitus	0.00125	0.0214	CbGpPWpGaD
Medrysone—Conjunctivitis—Glipizide—type 2 diabetes mellitus	0.00124	0.0261	CcSEcCtD
Medrysone—Visual disturbance—Gliclazide—type 2 diabetes mellitus	0.00121	0.0254	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ABCC8—type 2 diabetes mellitus	0.00119	0.0205	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—HSD3B2—type 2 diabetes mellitus	0.00114	0.0884	CrCbGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—type 2 diabetes mellitus	0.00111	0.0191	CbGpPWpGaD
Medrysone—Visual impairment—Glipizide—type 2 diabetes mellitus	0.0011	0.0232	CcSEcCtD
Medrysone—NR3C1—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00109	0.0187	CbGpPWpGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.00108	0.0185	CbGpPWpGaD
Medrysone—Visual impairment—Pioglitazone—type 2 diabetes mellitus	0.00106	0.0222	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—PCK1—type 2 diabetes mellitus	0.00104	0.0179	CbGpPWpGaD
Medrysone—Visual impairment—Glimepiride—type 2 diabetes mellitus	0.00103	0.0216	CcSEcCtD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—type 2 diabetes mellitus	0.00102	0.0175	CbGpPWpGaD
Medrysone—Visual disturbance—Irbesartan—type 2 diabetes mellitus	0.000954	0.02	CcSEcCtD
Medrysone—NR3C1—Circadian Clock—NCOA6—type 2 diabetes mellitus	0.000945	0.0162	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—type 2 diabetes mellitus	0.000945	0.0162	CbGpPWpGaD
Medrysone—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00094	0.0197	CcSEcCtD
Medrysone—Visual impairment—Bromocriptine—type 2 diabetes mellitus	0.00093	0.0195	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—type 2 diabetes mellitus	0.000906	0.0156	CbGpPWpGaD
Medrysone—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000895	0.0188	CcSEcCtD
Medrysone—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000878	0.0184	CcSEcCtD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000876	0.015	CbGpPWpGaD
Medrysone—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.000875	0.0184	CcSEcCtD
Medrysone—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000869	0.0182	CcSEcCtD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—type 2 diabetes mellitus	0.000867	0.0149	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptors—HNF4A—type 2 diabetes mellitus	0.000866	0.0149	CbGpPWpGaD
Medrysone—Conjunctivitis—Gliclazide—type 2 diabetes mellitus	0.000858	0.018	CcSEcCtD
Medrysone—Visual impairment—Glyburide—type 2 diabetes mellitus	0.00085	0.0179	CcSEcCtD
Medrysone—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000838	0.0176	CcSEcCtD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—type 2 diabetes mellitus	0.000822	0.0141	CbGpPWpGaD
Medrysone—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000792	0.0166	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—type 2 diabetes mellitus	0.000786	0.0135	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—type 2 diabetes mellitus	0.00077	0.0132	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—type 2 diabetes mellitus	0.00077	0.0132	CbGpPWpGaD
Medrysone—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.000763	0.016	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—type 2 diabetes mellitus	0.00075	0.0129	CbGpPWpGaD
Medrysone—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000725	0.0152	CcSEcCtD
Medrysone—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000724	0.0152	CcSEcCtD
Medrysone—NR3C1—Endoderm Differentiation—HNF1B—type 2 diabetes mellitus	0.000717	0.0123	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.000703	0.0121	CbGpPWpGaD
Medrysone—Pain—Glipizide—type 2 diabetes mellitus	0.000696	0.0146	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—HNF4A—type 2 diabetes mellitus	0.000684	0.0118	CbGpPWpGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—type 2 diabetes mellitus	0.000683	0.0117	CbGpPWpGaD
Medrysone—Drostanolone—SHBG—type 2 diabetes mellitus	0.000679	0.0525	CrCbGaD
Medrysone—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.000677	0.0142	CcSEcCtD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—LEP—type 2 diabetes mellitus	0.000668	0.0115	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—RETN—type 2 diabetes mellitus	0.000663	0.0114	CbGpPWpGaD
Medrysone—Pain—Sitagliptin—type 2 diabetes mellitus	0.000648	0.0136	CcSEcCtD
Medrysone—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000644	0.0111	CbGpPWpGaD
Medrysone—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.000637	0.0134	CcSEcCtD
Medrysone—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000632	0.0109	CbGpPWpGaD
Medrysone—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000603	0.0127	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.0006	0.0103	CbGpPWpGaD
Medrysone—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.0006	0.0126	CcSEcCtD
Medrysone—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.000599	0.0103	CbGpPWpGaD
Medrysone—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000597	0.0125	CcSEcCtD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000596	0.0102	CbGpPWpGaD
Medrysone—Drostanolone—AR—type 2 diabetes mellitus	0.000595	0.046	CrCbGaD
Medrysone—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00059	0.0124	CcSEcCtD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.000582	0.01	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000578	0.00993	CbGpPWpGaD
Medrysone—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000575	0.0121	CcSEcCtD
Medrysone—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000573	0.00984	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.00057	0.00979	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.000563	0.00967	CbGpPWpGaD
Medrysone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00056	0.0118	CcSEcCtD
Medrysone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000558	0.0117	CcSEcCtD
Medrysone—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.00055	0.00945	CbGpPWpGaD
Medrysone—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000546	0.0115	CcSEcCtD
Medrysone—Vision blurred—Metformin—type 2 diabetes mellitus	0.000544	0.0114	CcSEcCtD
Medrysone—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000533	0.00915	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000533	0.00915	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.000524	0.009	CbGpPWpGaD
Medrysone—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000513	0.0108	CcSEcCtD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000489	0.00841	CbGpPWpGaD
Medrysone—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000486	0.0102	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000484	0.00831	CbGpPWpGaD
Medrysone—Vision blurred—Losartan—type 2 diabetes mellitus	0.000483	0.0101	CcSEcCtD
Medrysone—Pain—Gliclazide—type 2 diabetes mellitus	0.000481	0.0101	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000474	0.00815	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000473	0.00812	CbGpPWpGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000465	0.00798	CbGpPWpGaD
Medrysone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000462	0.0097	CcSEcCtD
Medrysone—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.00046	0.0079	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000455	0.00781	CbGpPWpGaD
Medrysone—NR3C1—nerve—type 2 diabetes mellitus	0.000447	0.149	CbGeAlD
Medrysone—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.00044	0.00756	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000439	0.00754	CbGpPWpGaD
Medrysone—Pain—Orlistat—type 2 diabetes mellitus	0.000437	0.00918	CcSEcCtD
Medrysone—Drospirenone—AR—type 2 diabetes mellitus	0.000432	0.0334	CrCbGaD
Medrysone—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000421	0.00723	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000419	0.0072	CbGpPWpGaD
Medrysone—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000415	0.00713	CbGpPWpGaD
Medrysone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000415	0.00871	CcSEcCtD
Medrysone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000413	0.0319	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000409	0.00703	CbGpPWpGaD
Medrysone—SERPINA6—nephron tubule—type 2 diabetes mellitus	0.000399	0.133	CbGeAlD
Medrysone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000381	0.008	CcSEcCtD
Medrysone—Pain—Irbesartan—type 2 diabetes mellitus	0.00038	0.00798	CcSEcCtD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000379	0.00652	CbGpPWpGaD
Medrysone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000376	0.00791	CcSEcCtD
Medrysone—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000376	0.00646	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000371	0.00638	CbGpPWpGaD
Medrysone—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.000366	0.0283	CrCbGaD
Medrysone—Testosterone Propionate—AR—type 2 diabetes mellitus	0.000363	0.028	CrCbGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000359	0.00618	CbGpPWpGaD
Medrysone—Pain—Losartan—type 2 diabetes mellitus	0.000358	0.00751	CcSEcCtD
Medrysone—Hydrocortamate—NR3C1—type 2 diabetes mellitus	0.000354	0.0274	CrCbGaD
Medrysone—SERPINA6—kidney—type 2 diabetes mellitus	0.00035	0.117	CbGeAlD
Medrysone—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000348	0.0269	CrCbGaD
Medrysone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.000346	0.00594	CbGpPWpGaD
Medrysone—SERPINA6—cortex of kidney—type 2 diabetes mellitus	0.000341	0.114	CbGeAlD
Medrysone—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000338	0.00581	CbGpPWpGaD
Medrysone—Megestrol acetate—NR3C1—type 2 diabetes mellitus	0.000336	0.026	CrCbGaD
Medrysone—Medroxyprogesterone Acetate—SHBG—type 2 diabetes mellitus	0.000329	0.0254	CrCbGaD
Medrysone—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000329	0.00565	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000328	0.00563	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000328	0.00563	CbGpPWpGaD
Medrysone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000327	0.00688	CcSEcCtD
Medrysone—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000326	0.00559	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000317	0.00545	CbGpPWpGaD
Medrysone—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.00031	0.0239	CrCbGaD
Medrysone—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000309	0.0239	CrCbGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.000309	0.00531	CbGpPWpGaD
Medrysone—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000308	0.00647	CcSEcCtD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000302	0.00519	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000301	0.00517	CbGpPWpGaD
Medrysone—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000297	0.0051	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—AR—type 2 diabetes mellitus	0.000289	0.0223	CrCbGaD
Medrysone—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000288	0.00496	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000283	0.00486	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00028	0.00481	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000274	0.0047	CbGpPWpGaD
Medrysone—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000273	0.0211	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000273	0.00468	CbGpPWpGaD
Medrysone—Methyltestosterone—AR—type 2 diabetes mellitus	0.000272	0.021	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000271	0.00466	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.00027	0.00464	CbGpPWpGaD
Medrysone—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000266	0.0206	CrCbGaD
Medrysone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000264	0.00555	CcSEcCtD
Medrysone—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.00026	0.00446	CbGpPWpGaD
Medrysone—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000257	0.0199	CrCbGaD
Medrysone—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000255	0.0197	CrCbGaD
Medrysone—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000252	0.00433	CbGpPWpGaD
Medrysone—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000249	0.00429	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000245	0.00421	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000245	0.0042	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000241	0.00414	CbGpPWpGaD
Medrysone—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.000233	0.018	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000223	0.00382	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000222	0.00381	CbGpPWpGaD
Medrysone—SERPINA6—liver—type 2 diabetes mellitus	0.000221	0.0738	CbGeAlD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000219	0.00376	CbGpPWpGaD
Medrysone—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000217	0.0723	CbGeAlD
Medrysone—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000211	0.00363	CbGpPWpGaD
Medrysone—Finasteride—CYP3A4—type 2 diabetes mellitus	0.000207	0.016	CrCbGaD
Medrysone—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	0.000205	0.0159	CrCbGaD
Medrysone—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	0.000202	0.0156	CrCbGaD
Medrysone—Medroxyprogesterone Acetate—NR3C1—type 2 diabetes mellitus	0.000196	0.0151	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000195	0.00336	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000194	0.00333	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000194	0.00333	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000192	0.00331	CbGpPWpGaD
Medrysone—Progesterone—SHBG—type 2 diabetes mellitus	0.00019	0.0147	CrCbGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000185	0.00318	CbGpPWpGaD
Medrysone—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000183	0.00315	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000183	0.00314	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000183	0.00314	CbGpPWpGaD
Medrysone—Prednisolone—NR3C1—type 2 diabetes mellitus	0.000181	0.014	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.00018	0.0031	CbGpPWpGaD
Medrysone—Testosterone—SHBG—type 2 diabetes mellitus	0.00018	0.0139	CrCbGaD
Medrysone—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	0.000176	0.00302	CbGpPWpGaD
Medrysone—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000175	0.0582	CbGeAlD
Medrysone—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000173	0.00298	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	0.00017	0.00292	CbGpPWpGaD
Medrysone—Progesterone—AR—type 2 diabetes mellitus	0.000167	0.0129	CrCbGaD
Medrysone—Drospirenone—PTGS2—type 2 diabetes mellitus	0.000166	0.0129	CrCbGaD
Medrysone—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	0.000165	0.00284	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	0.000165	0.00283	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	0.000165	0.00283	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	0.000165	0.00283	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	0.000161	0.00277	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	0.000159	0.00273	CbGpPWpGaD
Medrysone—Paramethasone—CYP3A4—type 2 diabetes mellitus	0.000158	0.0122	CrCbGaD
Medrysone—Testosterone—AR—type 2 diabetes mellitus	0.000158	0.0122	CrCbGaD
Medrysone—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000157	0.0523	CbGeAlD
Medrysone—Fluorometholone—CYP3A4—type 2 diabetes mellitus	0.000154	0.0119	CrCbGaD
Medrysone—NR3C1—kidney—type 2 diabetes mellitus	0.000153	0.0512	CbGeAlD
Medrysone—NR3C1—pancreas—type 2 diabetes mellitus	0.000152	0.0508	CbGeAlD
Medrysone—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000149	0.0498	CbGeAlD
Medrysone—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	0.000149	0.0115	CrCbGaD
Medrysone—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	0.000144	0.00247	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000143	0.00245	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	0.000141	0.00241	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	0.000139	0.00238	CbGpPWpGaD
Medrysone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	0.000139	0.0107	CrCbGaD
Medrysone—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000138	0.0461	CbGeAlD
Medrysone—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	0.000138	0.00237	CbGpPWpGaD
Medrysone—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	0.000134	0.00231	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	0.000133	0.00229	CbGpPWpGaD
Medrysone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	0.000132	0.00227	CbGpPWpGaD
Medrysone—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	0.000131	0.00225	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	0.000127	0.00218	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000118	0.00203	CbGpPWpGaD
Medrysone—Medroxyprogesterone Acetate—CYP3A4—type 2 diabetes mellitus	0.000113	0.00877	CrCbGaD
Medrysone—Progesterone—NR3C1—type 2 diabetes mellitus	0.000113	0.00873	CrCbGaD
Medrysone—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	0.000107	0.00825	CrCbGaD
Medrysone—Prednisolone—CYP3A4—type 2 diabetes mellitus	0.000105	0.00813	CrCbGaD
Medrysone—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000101	0.00174	CbGpPWpGaD
Medrysone—Progesterone—CYP1A2—type 2 diabetes mellitus	9.89e-05	0.00765	CrCbGaD
Medrysone—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	9.88e-05	0.0017	CbGpPWpGaD
Medrysone—NR3C1—liver—type 2 diabetes mellitus	9.69e-05	0.0323	CbGeAlD
Medrysone—Methyltestosterone—ALB—type 2 diabetes mellitus	9.31e-05	0.0072	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	8.87e-05	0.00152	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	8.78e-05	0.00151	CbGpPWpGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	8.71e-05	0.0015	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	8.35e-05	0.00143	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	8.29e-05	0.00142	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	8.19e-05	0.00141	CbGpPWpGaD
Medrysone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	8.11e-05	0.00139	CbGpPWpGaD
Medrysone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	8.04e-05	0.00621	CrCbGaD
Medrysone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	8.03e-05	0.00138	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	7.99e-05	0.00137	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	7.55e-05	0.0013	CbGpPWpGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	7.53e-05	0.00129	CbGpPWpGaD
Medrysone—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	7.46e-05	0.00128	CbGpPWpGaD
Medrysone—Progesterone—CYP3A4—type 2 diabetes mellitus	6.55e-05	0.00506	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	6.45e-05	0.00111	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	6.21e-05	0.00107	CbGpPWpGaD
Medrysone—Testosterone—CYP3A4—type 2 diabetes mellitus	6.19e-05	0.00479	CrCbGaD
Medrysone—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	6.02e-05	0.00103	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	5.69e-05	0.000978	CbGpPWpGaD
Medrysone—Testosterone—ALB—type 2 diabetes mellitus	5.4e-05	0.00418	CrCbGaD
Medrysone—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	5.21e-05	0.000894	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	5.13e-05	0.000882	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	4.97e-05	0.000855	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	4.97e-05	0.000855	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	4.88e-05	0.000839	CbGpPWpGaD
Medrysone—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	4.62e-05	0.000794	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	4.23e-05	0.000727	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	3.94e-05	0.000678	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	3.63e-05	0.000624	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	3.6e-05	0.000618	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	3.18e-05	0.000546	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	2.99e-05	0.000514	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	2.47e-05	0.000425	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.23e-05	0.000382	CbGpPWpGaD
Medrysone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	9.77e-06	0.000168	CbGpPWpGaD
